95 related articles for article (PubMed ID: 15899679)
21. Comparison of the diagnostic performance of three natriuretic peptides in hemodialysis patients: which is the appropriate biomarker?
Artunc F; Mueller C; Breidthardt T; Twerenbold R; Rettig I; Usta E; Häring HU; Friedrich B
Kidney Blood Press Res; 2012; 36(1):172-81. PubMed ID: 23108497
[TBL] [Abstract][Full Text] [Related]
22. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
[TBL] [Abstract][Full Text] [Related]
23. [BNP and dyspnea: proposition of a diagnostic strategy based on two cut-off].
Ababsa R; Jourdain P; Funck F; Deschamps P; Sadeg N
Ann Biol Clin (Paris); 2005; 63(2):213-6. PubMed ID: 15771980
[TBL] [Abstract][Full Text] [Related]
24. Measurement of amino terminal propeptide of type III procollagen (PIIINP) employing the ADVIA Centaur platform. Validation, reference interval and comparison to UniQ RIA.
Knudsen CS; Heickendorff L; Nexo E
Clin Chem Lab Med; 2014 Feb; 52(2):237-41. PubMed ID: 24114914
[TBL] [Abstract][Full Text] [Related]
25. Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration.
Bargnoux AS; Klouche K; Fareh J; Barazer I; Villard-Saussine S; Dupuy AM; Leray-Moragues H; Giuliani I; Canaud B; Cristol JP
Clin Chem Lab Med; 2008; 46(7):1019-24. PubMed ID: 18624622
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Abbott AxSYM and Roche Elecsys 2010 for measurement of BNP and NT-proBNP.
Chien TI; Chen HH; Kao JT
Clin Chim Acta; 2006 Jul; 369(1):95-9. PubMed ID: 16515777
[TBL] [Abstract][Full Text] [Related]
27. Method comparison of cardiac marker assays on PATHFAST, StratusCS, AxSYM, Immulite 2000, triage, elecsys and cardiac reader.
Peetz D; Schweigert R; Jachmann N; Post F; Schinzel H; Lackner KJ
Clin Lab; 2006; 52(11-12):605-14. PubMed ID: 17175892
[TBL] [Abstract][Full Text] [Related]
28. Superior predictive value for NTproBNP compared with high sensitivity cTnT in dialysis patients: a pilot prospective observational study.
Voroneanu L; Siriopol D; Nistor I; Apetrii M; Hogas S; Onofriescu M; Covic A
Kidney Blood Press Res; 2014; 39(6):636-47. PubMed ID: 25571877
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Bayer Advia Centaur immunoassay results obtained on samples collected in four different Becton Dickinson Vacutainer tubes.
Morovat A; James TS; Cox SD; Norris SG; Rees MC; Gales MA; Taylor RP
Ann Clin Biochem; 2006 Nov; 43(Pt 6):481-7. PubMed ID: 17132279
[TBL] [Abstract][Full Text] [Related]
30. The plasma level of brain natriuretic peptide is increased in malnourished hemodialysis patients.
Chazot C; Jean G; Vo-Van C; Collonge C; Terrat JC; Vanel T; Lorriaux C; Hurot JM; Charra B
Blood Purif; 2009; 28(3):187-92. PubMed ID: 19648737
[TBL] [Abstract][Full Text] [Related]
31. [Value of plasma brain natriuretic peptide detection in cardiac function assessment in hemodialysis patients].
Shao YH; Lai YQ; Lin AZ; Kong YZ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul; 25(7):892-4. PubMed ID: 16027094
[TBL] [Abstract][Full Text] [Related]
32. Brain natriuretic peptide levels predict perioperative events in cardiac patients undergoing noncardiac surgery: a prospective study.
Leibowitz D; Planer D; Rott D; Elitzur Y; Chajek-Shaul T; Weiss AT
Cardiology; 2008; 110(4):266-70. PubMed ID: 18073483
[TBL] [Abstract][Full Text] [Related]
33. Falsely high B-type natriuretic peptide concentration in patients without heart failure attributed to AxSYM assay: case series of eight subjects.
Jin C; Kim MH; Guo LZ; Li SH; Han JY
ESC Heart Fail; 2015 Mar; 2(1):37-39. PubMed ID: 28834642
[TBL] [Abstract][Full Text] [Related]
34. Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction.
Odar-Cederlöf I; Bjellerup P; Williams A; Blagg CR; Twardowski Z; Ting G; Kjellstrand CM
Hemodial Int; 2006 Oct; 10(4):394-8. PubMed ID: 17014518
[TBL] [Abstract][Full Text] [Related]
35. Analytical relationships among Biosite, Bayer, and Roche methods for BNP and NT-proBNP.
Sykes E; Karcher RE; Eisenstadt J; Tushman DA; Balasubramaniam M; Gusway J; Perason VJ
Am J Clin Pathol; 2005 Apr; 123(4):584-90. PubMed ID: 15743748
[TBL] [Abstract][Full Text] [Related]
36. Analytical and clinical performance of three natriuretic peptide tests in the emergency room.
Gorissen C; Baumgarten R; de Groot M; van Haren E; Kragten H; Leers M
Clin Chem Lab Med; 2007; 45(5):678-84. PubMed ID: 17484634
[TBL] [Abstract][Full Text] [Related]
37. Higher parathyroid hormone (PTH) concentrations with the Architect PTH assay than with the Elecsys assay in hemodialysis patients, and a simple way to standardize these two methods.
Monge M; Jean G; Bacri JL; Lemaitre V; Masy E; Joly D; Souberbielle JC
Clin Chem Lab Med; 2009; 47(3):362-6. PubMed ID: 19199835
[TBL] [Abstract][Full Text] [Related]
38. Evidence for functional heterogeneity of circulating B-type natriuretic peptide.
Liang F; O'Rear J; Schellenberger U; Tai L; Lasecki M; Schreiner GF; Apple FS; Maisel AS; Pollitt NS; Protter AA
J Am Coll Cardiol; 2007 Mar; 49(10):1071-8. PubMed ID: 17349887
[TBL] [Abstract][Full Text] [Related]
39. The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex.
Clerico A; Del Ry S; Maffei S; Prontera C; Emdin M; Giannessi D
Clin Chem Lab Med; 2002 Apr; 40(4):371-7. PubMed ID: 12059078
[TBL] [Abstract][Full Text] [Related]
40. Value of B-type natriuretic peptide in diagnosing left ventricular dysfunction in dialysis-dependent patients.
Zeng C; Wei T; Jin L; Wang L
Intern Med J; 2006 Sep; 36(9):552-7. PubMed ID: 16911545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
